TrialAnti-cancer drugs2013

A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.

Przemyslaw W Twardowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.